Cellectis (CLLS) Receivables - Net (2013 - 2026)

Cellectis (CLLS) posted quarterly Receivables - Net of $5.2 million for Q1 2026, down 34.55% year-over-year from $7.9 million in Q1 2025, and down 64.22% quarter-over-quarter from $14.4 million in Q4 2025.

Cellectis (CLLS) Receivables - Net (2013 - 2026) Analysis & Trends

Cellectis' Receivables - Net history runs 14 years deep, the most recent figure standing at $5.2 million for Q1 2026.

  • In Q1 2026, Receivables - Net fell 34.55% year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (down 34.55% YoY), while the FY2025 annual figure was $14.4 million, up 114.45% from the prior year.
  • Receivables - Net for Q1 2026 stood at $5.2 million, down from $14.4 million in the prior quarter.
  • The five-year high for Receivables - Net was $21.8 million in Q1 2022, with the low at $393000.0 in Q3 2023.
  • The 5-year median for Receivables - Net is $6.7 million (2024), against an average of $6.8 million.
  • The sharpest annual moves came in 2022 and 2024: Receivables - Net slumped 96.21% in 2022, then jumped 2744.78% in 2024.
  • Cellectis' Receivables - Net stood at $772000.0 in 2022, then fell by 26.3% to $569000.0 in 2023, then surged by 1079.96% to $6.7 million in 2024, then surged by 114.45% to $14.4 million in 2025, then sank by 64.22% to $5.2 million in 2026.
  • Business Quant data shows CLLS's Receivables - Net at $5.2 million in Q1 2026, $14.4 million in Q4 2025, and $8.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Cellectis 306.61 Mn 120.95 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 5.15 Mn
Mar 31, 2026 5.15 Mn
Dec 31, 2025 14.40 Mn
Dec 31, 2025 14.40 Mn
Sep 30, 2025 8.06 Mn
Sep 30, 2025 8.06 Mn
Jun 30, 2025 8.78 Mn
Jun 30, 2025 8.78 Mn
Mar 31, 2025 7.87 Mn
Mar 31, 2025 7.87 Mn
Dec 31, 2024 6.71 Mn
Dec 31, 2024 6.71 Mn
Sep 30, 2024 11.18 Mn
Sep 30, 2024 11.18 Mn
Jun 30, 2024 9.74 Mn
Jun 30, 2024 9.74 Mn
Mar 31, 2024 16.04 Mn
Mar 31, 2024 16.04 Mn
Dec 31, 2023 569,000.00
Dec 31, 2023 569,000.00